What is GLP-1 and Where Does it Come From?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1, or glucagon-like peptide-1, is a regulatory hormone your body produces to control hunger signals and blood glucose levels. When used therapeutically, GLP-1 medications have demonstrated significant weight loss and metabolic improvements in clinical trials. PlexusDx specializes in delivering compounded GLP-1 therapies tailored to your individual needs.

GLP-1 Hormone Definition and Natural Function

Your intestines release GLP-1 naturally when you eat, especially after consuming protein or carbohydrates. This hormone communicates with your brain's appetite centers to signal fullness, slow stomach emptying, and regulate blood sugar spikes. The result is reduced hunger, better glucose control, and sustained energy—all without external medication. Scientists discovered that higher GLP-1 levels correlate with lower body weight and improved metabolic health in observational studies.

The body's GLP-1 production declines with age and in people living with obesity, which is why synthetic versions became medically valuable. Pharmaceutical researchers identified that potent, long-acting GLP-1 analogs could mimic or enhance these natural signals beyond what the body produces alone. This discovery opened a new category of weight management therapy grounded in genuine human physiology rather than artificial appetite suppressants.

Where GLP-1 Medications Originally Come From

The first GLP-1 analogs were derived from peptides found in the venom of the Gila monster lizard, a species native to the southwestern United States. Researchers in the 1990s observed that this venom contained a peptide sequence remarkably similar to human GLP-1, prompting chemists to develop synthetic versions for therapeutic use. This natural-origin discovery led to the first GLP-1 injection approved for diabetes management in 2005, later adapted for weight loss applications.

Modern GLP-1 medications like semaglutide are manufactured through recombinant DNA technology in licensed pharmaceutical and compounding facilities. PlexusDx sources its compounded semaglutide from licensed 503A compounding pharmacies, which follow rigorous quality and sterility standards. This manufacturing approach ensures consistent potency and purity while keeping medications accessible and affordable compared to brand-name alternatives.

How GLP-1 Medications Work in Your Body

Once injected or taken orally, GLP-1 analogs bind to GLP-1 receptors throughout your digestive system and brain. This binding triggers multiple metabolic pathways: your stomach empties more slowly, your brain receives stronger fullness signals, and your pancreas optimizes insulin release in response to meals. The combined effect reduces calorie intake naturally without willpower-dependent restriction, with average weight reductions of 15–22% in clinical trials when combined with lifestyle changes.

The medication's impact extends beyond appetite control. GLP-1 analogs improve insulin sensitivity, reduce inflammation, and may offer cardiovascular protection—benefits documented in major randomized trials over the past five years. Your body continues producing its own GLP-1 while the medication enhances those signals, creating a synergistic effect rather than replacing your natural system entirely.

PlexusDx Compounded Semaglutide vs. Brand-Name Alternatives

PlexusDx offers compounded semaglutide injection starting at $149 per month from licensed 503A compounding pharmacies, with no membership fees, insurance requirements, or flat per-compound pricing tiers. Your dose may need to go up. Your price won't. This flat-rate model removes financial barriers to dose optimization, allowing your healthcare provider to adjust strength based on clinical response rather than budget constraints.

Brand-name GLP-1 therapies often cost $900–$1,500 monthly and may be restricted by insurance coverage, deductibles, or prior authorization delays. PlexusDx serves all 50 states, accepts HSA and FSA funds, and pairs your medication with optional genetic testing through the Precision Peptide Genetic Test ($99 add-on). This test identifies your individual peptide-pathway genetics across 14 metabolic pathways and 49 peptides, enabling truly personalized therapy selection and dosing strategies.

Understanding GLP-1 Variants: Semaglutide vs. Tirzepatide

Semaglutide is a pure GLP-1 receptor agonist, meaning it activates only the GLP-1 pathway to reduce appetite and improve blood sugar. Tirzepatide, by contrast, is a dual GLP-1 and GIP receptor agonist, engaging two appetite-regulating pathways simultaneously for potentially stronger effects. PlexusDx offers both as compounded injections and oral formulations, plus a GLP-Squared combination option that blends semaglutide and tirzepatide in a single dose.

Your choice depends on personal genetics, medical history, and response goals. The Precision Peptide Genetic Test screens for key variants in GLP1R (rs6923761), GIPR (rs1800437), and other genes that influence which GLP-1 therapy produces optimal results for your metabolism. This precision approach prevents trial-and-error prescribing and accelerates your path to sustainable weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is GLP-1 a natural hormone or a synthetic drug?

GLP-1 is a hormone your body produces naturally. Medications that mimic or enhance GLP-1 are synthetic analogs created in laboratories, but they work by leveraging your body's own biological signaling systems. This makes GLP-1 therapy fundamentally different from older weight-loss drugs that artificially suppressed appetite without addressing metabolic regulation.

How much weight can I expect to lose with GLP-1 therapy?

Clinical trials show average weight reductions of 15–22% of body weight over 68 weeks when GLP-1 medications are combined with lifestyle changes. Individual results vary based on genetics, adherence, diet quality, and exercise habits. PlexusDx's Precision Peptide Genetic Test can help predict your likely response category and guide dosing for faster, more sustainable results.

Why is PlexusDx semaglutide cheaper than brand-name options?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies rather than paying for brand-name manufacturing and marketing costs. Starting at $149 per month with no insurance requirement, PlexusDx removes intermediaries and keeps pricing flat regardless of dose level, making therapy financially accessible across all 50 states.

Are compounded GLP-1 medications as safe as FDA-approved brands?

PlexusDx compounded medications come from licensed 503A compounding pharmacies that meet strict federal quality, sterility, and potency standards. While compounded medications are not FDA-approved, 503A compounders operate under intensive regulatory oversight. Your prescribing physician monitors your response and tolerability throughout treatment to ensure safety.

Can genetic testing help me choose between semaglutide and tirzepatide?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 49 peptides and 14 metabolic pathways, including GLP1R and GIPR variants that influence medication response. This data helps your provider select semaglutide, tirzepatide, or GLP-Squared combination therapy most likely to deliver results for your unique biology.

Related Reading

• Maximus Glp 1
• Found Glp 1
• Orderly Meds Glp 1
• Henry Meds Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.